Skip to main content
. 2022 Apr 5;23(7):4027. doi: 10.3390/ijms23074027

Table 6.

Reported RSV results in bone regeneration.

Ref. Authors (Year) Type of the Study/Days Aim of the Study Materials Results
[276] Zhang et.al
2020
Research in vitro
  1. If RSV with or without SrRn has differentiating power on the MSC;

  2. If RSV with or without SrRn inhibits the action of osteoclasts;

  3. If RSV with or without SrRn induces angiogenesis

  4. If in rats rehabilitated with 3D scaffolds with RSV associated or not with SrRn, there is bone formation

  • − Scaffold only

  • − Scaffold with SrRn

  • − Scaffold with RSV

  • − Scaffold with RSV and SrRn

  1. MSC proliferation in scaffolds with SrRn is greater than other groups;

  2. Action of osteoclasts is inhibited in scaffolds with RSV, SrRn and both;

  3. Angiogenic effect is greatest in scaffolds with RSV;

  4. High bone formation in mandible with scaffolds with RVS and SrRn compared to the other two groups.

[95] Borsani et.al
2018
Research in vitro The researchers wanted to see how CGFs and/or resveratrol affected the proliferation and differentiation of human osteoblasts, whether they were treated with bisphosphonates or not. Osteoblast growth medium (OGM): control group
OGM + RSV 10 µM
OGM + AL 5 µM
OGM + ZOL 5 µM
OGM + AL 5 µM +RSV 10 µM
OGM + ZOL 5 µM +RSV 10 µM
OGM + CGF
OGM + CGF + RSV 10 µM
OGM + CGF + AL 5 µM
OGM + CGF + ZOL 5 µM
OGM + CGF + RSV 10 µM + AL 5 µM
OGM + CGF + RSV 10 µM + ZOL 5 µM
  1. CGF and RSV both have an osteogenic impact and protect ZOL-treated osteoblasts;

  2. In osteoblasts treated with RSV + ZOL or CGF + RSV + ZOL, OPG levels are higher;

  3. BMP-2 levels rose sharply in osteoblasts treated with CGF + RSV + AL or CGF + RSV + ZOL, but not as much as in osteoblasts treated with CGF + ZOL;

  4. There is a rise in SIRT-1 and Col 1 in osteoblastic cells treated with RSV + CGF + ZOL;

  5. Human osteoblastic cells treated with RSV deposited substantial amounts of calcium.